TWiV 1104: Clinical update with Dr. Daniel Griffin
04/13/24 • 46 min
1 Listener
In his weekly clinical update, Dr. Griffin reviews recent statistics on the circulation of measles before addressing results of Pfizer’s phase 3 RSV vaccine clinical trial for adults under 60, RSV, influenza and SARS-CoV-2 circulation, differences between rural and urban communities dealing with SARS-CoV-2 infections, the latest statistics on influenza and COVID-19 circulation, restates the guidelines for spring administration of COVID vaccines boosters, discusses the emergency use application of a pre-exposure prophylactic. revised guidelines for how to treat respiratory viral infection guidelines by the CDC, continues to dispel the myth of viral rebound, revised guidelines SARS-CoV-2 treatment and how to treat respiratory viral infections, when to use steroids and the benefits of convalescent plasma, what do when healthcare workers succumb to SARS-CoV-2 infection, how long COVID affects the brain and associates with an increase in allergic incidents as well as if post SARS-CoV-2 infected patients are unable to exercise or have functional limitations. For more information about this body of work, listen to TWiV 1088.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Measles tracking (CDC)
- Measles just this year (MMWR)
- ABRYSVO phase 3 results (Pfizer)
- RSV surveillance (CDC)
- Influenza/flu surveillance (CDC)
- Provisional deaths due to COVID-19 (CDC)
- COVID-19 national trend (CDC)
- COVID-19 wastewater testing (biobot)
- Variant tracker (CDC)
- Rural-urban differences in COVID-19 mortality and hospitalizations (OFID)
- Spring COVID-19 booster recommendations (CIDRAP)
- Older adult spring booster available (CDC)
- Advisory committee for immunization practices spring 2024 COVID-19 boosters (CDC)
- EUA for pemgarda (FDA)
- CDC Quarantine guidelines (CDC)
- NIH COVID-19 treatment guidelines (NIH)
- Nirmatrelvir for vaccinated or unvaccinated COVID-19 patients (NEJM)
- Assessment for clinical usefulness (NEJM)
- Molnupiravir safety and efficacy (JMV)
- Convalescent plasma recommendation for immunocompromised (IDSociety)
- Updated respiratory virus guidances (CDC)
- What do when your heathcare provider is infected with SARS-CoV-2 (CDC)
- Managing healthcare staffing shortages (CDC)
- Steroids,
In his weekly clinical update, Dr. Griffin reviews recent statistics on the circulation of measles before addressing results of Pfizer’s phase 3 RSV vaccine clinical trial for adults under 60, RSV, influenza and SARS-CoV-2 circulation, differences between rural and urban communities dealing with SARS-CoV-2 infections, the latest statistics on influenza and COVID-19 circulation, restates the guidelines for spring administration of COVID vaccines boosters, discusses the emergency use application of a pre-exposure prophylactic. revised guidelines for how to treat respiratory viral infection guidelines by the CDC, continues to dispel the myth of viral rebound, revised guidelines SARS-CoV-2 treatment and how to treat respiratory viral infections, when to use steroids and the benefits of convalescent plasma, what do when healthcare workers succumb to SARS-CoV-2 infection, how long COVID affects the brain and associates with an increase in allergic incidents as well as if post SARS-CoV-2 infected patients are unable to exercise or have functional limitations. For more information about this body of work, listen to TWiV 1088.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Measles tracking (CDC)
- Measles just this year (MMWR)
- ABRYSVO phase 3 results (Pfizer)
- RSV surveillance (CDC)
- Influenza/flu surveillance (CDC)
- Provisional deaths due to COVID-19 (CDC)
- COVID-19 national trend (CDC)
- COVID-19 wastewater testing (biobot)
- Variant tracker (CDC)
- Rural-urban differences in COVID-19 mortality and hospitalizations (OFID)
- Spring COVID-19 booster recommendations (CIDRAP)
- Older adult spring booster available (CDC)
- Advisory committee for immunization practices spring 2024 COVID-19 boosters (CDC)
- EUA for pemgarda (FDA)
- CDC Quarantine guidelines (CDC)
- NIH COVID-19 treatment guidelines (NIH)
- Nirmatrelvir for vaccinated or unvaccinated COVID-19 patients (NEJM)
- Assessment for clinical usefulness (NEJM)
- Molnupiravir safety and efficacy (JMV)
- Convalescent plasma recommendation for immunocompromised (IDSociety)
- Updated respiratory virus guidances (CDC)
- What do when your heathcare provider is infected with SARS-CoV-2 (CDC)
- Managing healthcare staffing shortages (CDC)
- Steroids,
Previous Episode
TWiV 1103: Jason 'Spike' McLellan
Vincent travels to the University of Texas in Austin to speak with speak with Jason McLellan about his career and his research on the SARS-CoV-2 spike protein, including the effect of adding two proline residues, its effect on other viral spike glycoproteins, and general approaches to vaccine design.
Hosts: Vincent Racaniello and Rich Condit
Guest: Jason McLellan
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- MicrobeTV Discord Server
- MicrobeTV store at Cafepress
- Become a member of ASV (asv.org)
- The New City by Dickson Despommier
- Prefusion-stabilized SARS-CoV-2 spikes (Science)
- Structure-based vaccine design (Curr Opin Immunol)
- Prefusion-stabilized SARS-CoV-2 S2-only antigen (Nat Comm)
- Stabilized coronavirus spike stem elicits broadly protective antibody (Cell Rep)
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your virology questions and comments to [email protected]
Next Episode
TWiV 1105: All the T and B in China
TWiV reviews influenza H5N1 in North American cows and in birds throughout New York City, polio health emergency extended, ChatGPT to control vaccine hesitancy, increasing viral hepatitis worldwide, dengue public health alert in Puerto Rico, cherry trees drowning in Washington DC, death of iron lung Paul, origin and dispersal history of hepatitis B virus in Eastern Eurasia, and antibody-independent protection against heterologous SARS-CoV-2 challenge.
Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Kathy Spindler
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- MicrobeTV Discord Server
- MicrobeTV store at Cafepress
- Become a member of ASV (asv.org)
- The New City by Dickson Despommier (blog post)
- Navigating the U.S. Immigration System webinar
- International Conferene on Pandemic Preparedness
- Avian influenza in dairy cows North Carolina and South Dakota
- H5N1 clade 2.3.4.4 Pathogenic flu throughout NYC
- Polio from Afghanistan to Pakistan extending public health emergency
- CHAT GPT to combat vaccine hesitancy
- Viral hepatitis worldwide
- Dengue public health alert in Puerto Rico
- Cherry trees being drowned by water level rise in DC
- Paul in iron lung dies (NPR)
- Hepatitis B virus in Eastern Eurasia (Nat Comm)
- Antibody-independent protection against heterologous SARS-CoV-2 (Nature)
- Timestamps by Jolene. Thanks!
Brianne – Do Other Planets Have Solar Eclipses? Kathy – Radcliffe Wave and Mt. Etna smoke rings with video Rich – Spongy Oak Apple Gall Wasp (Amphibolips confluenta) Life cycle; Gall formation Alan – Rogue attempt to clone giant sheep for captive hunting Vincent –
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/this-week-in-virology-80331/twiv-1104-clinical-update-with-dr-daniel-griffin-48696073"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to twiv 1104: clinical update with dr. daniel griffin on goodpods" style="width: 225px" /> </a>
Copy